Vaping has surpassed all other forms of tobacco use in middle- and high-schoolers. New research led by Mark Olfert, an associate professor in the West Virginia University School of Medicine, suggests if teenagers continue to vape into adulthood, the cardiovascular effects may, by some measures, be as dire as if they’d smoked cigarettes.
An international team of researchers has shown in mice that a healthy gut microbiome is important for recovery after a heart attack.
A team of nurses and physicians has received a four-year, $3 million grant from the National Heart, Lung, and Blood Institute to extend traditional HIV treatment protocols to improve the cardiovascular health of people living with HIV.
A side effect of opioid use is an infection of the heart valves called drug-associated infective endocarditis. Researchers at the University of North Carolina at Chapel Hill have found a tenfold increase in the number of hospitalizations and surgeries for endocarditis in the past decade.
A new nationwide study has found that a tiny clip placed in the heart to fix a leaky mitral valve drastically decreases the risk of both dying and returning to the hospital for heart failure patients.
In a new study, researchers have found that the gut microbiome appears to play a key role in how well the body accepts a transplanted heart. The scientists found a causal relationship between the presence of certain microbes and transplant outcome.
Analyzing data from more than 400,000 people, researchers at Washington University School of Medicine in St. Louis have found that consuming one to two drinks four or more times per week — an amount deemed healthy by current guidelines — increases the risk of premature death by 20 percent.
Patients with “broken heart” syndrome still face considerable risk of hospital readmission and in-hospital death.
Chris M. Gonzalez, MD, MBA, FACS, has been named the Albert J. Jr. and Claire R. Speh professor and chair of the department of urology of Loyola Medicine and Loyola University Chicago Stritch School of Medicine.
Delaying pregnancy may increase the risk of cardiovascular disease in both women and their children, with boys at higher risk of disease, according to a new study. Researchers from the University of Alberta in Canada will present their findings today at the American Physiological Society’s (APS) Cardiovascular, Renal and Metabolic Diseases: Sex-Specific Implications for Physiology conference in Knoxville, Tenn.
Mount Sinai Health System urges the general public, especially students, to learn lifesaving CPR and how to use an automated external defibrillator to reduce sudden cardiac death rates.
A relatively new accelerated diagnostic protocol is effective in identifying emergency department patients with acute chest pain who can be safely sent home without being hospitalized or undergoing comprehensive cardiac testing, according to researchers at Wake Forest Baptist Medical Center.
A commonly used biomarker of kidney disease may also indicate lung problems, particularly COPD, or chronic obstructive pulmonary disease, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine.
Vanderbilt University Medical Center’s Cardiac Surgery Team performed Tennessee’s first total artificial heart implantation Wednesday, Sept. 26, on a 56-year-old man with congestive heart failure.
Cardiologists at Henry Ford Hospital performed the first implantation in the United States of a device approved for use in Europe for hard-to-treat angina. The Neovasc Reducer was successfully implanted in a middle-aged, Detroit-area man on June 19. Within six to eight weeks, tissue then grows over the mesh, narrowing the passageway. The patient described greatly diminished symptoms at a recent follow-up.
Northern Arizona University professor Amirhossein Arzani authored a paper about which computational modeling of blood is more accurate when applied to monitoring the movement of blood through the human body, which affects how doctors treat patients with heart disease.
A person’s biological sex can be a defining factor in how well—or how poorly—they respond to disease, therapy and recovery. Experts at the forefront of sex-specific research will convene next week at the sixth APS conference on sex differences in cardiovascular and renal physiology. The Cardiovascular, Renal and Metabolic Diseases: Sex-Specific Implications for Physiology conference will be held September 30–October 3 in Knoxville, Tenn.
A University of Adelaide-led team of researchers has found a link between sudden cardiac death (when the heart suddenly stops beating) and a common heart condition known as mitral valve prolapse that affects around 12 in every 1000 people worldwide.
Renowned experts collaborate to expand the comprehensive cardiac services offered in Monmouth and Ocean counties.
The first randomized trial of its kind was unable to establish non-inferiority of oral anticoagulation (OAC) alone to combined OAC and a single antiplatelet agent (APT) in patients with atrial fibrillation (AF) and stable coronary artery disease beyond one year after stent implantation.
Results from the Lipid-Rich Plaque (LRP) study demonstrate the correlation between the presence of non-flow-limiting, non-intervened upon, lipid-rich plaques detected by NIRS-IVUS imaging and the development of a major adverse cardiac event (MACE) from a de novo culprit lesion at both the patient level (vulnerable patients) and segment level (vulnerable plaques) within 24 months post intravascular imaging.
The first study designed to determine the benefits of intravascular ultrasound (IVUS) guidance over angiography guidance during drug-eluting stent (DES) implantation in all-comer patients found that IVUS improved clinical outcomes by lowering the rate of target vessel failure at one year.
The Cardiovascular Research Foundation (CRF) is pleased to announce that Aria CV has won the TCT 2018 Shark Tank Competition which took place during the Transcatheter Cardiovascular Therapeutics (TCT) 2018, the world’s premier educational meeting specializing in interventional cardiovascular medicine. The winner was also presented with the Jon DeHaan Foundation Award for Interventional Innovation today in the Main Arena of the San Diego Convention Center.
Data presented today from the randomized COAPT trial, which have the potential to significantly change current clinical practice, found that patients with heart failure and secondary mitral regurgitation (MR) who remained symptomatic despite maximally tolerated medical therapy demonstrated reduced rates of hospitalizations and death, as well as improved quality-of-life and functional capacity after being treated with the transcatheter MitraClip device.
The first randomized study to compare general versus local anesthesia during transcatheter aortic valve replacement (TAVR) in patients with intermediate to high surgical risk found local anesthesia to be both safe and effective. In addition, the study found that a current generation balloon-expandable valve had similar outcomes to a current generation self-expanding one.
A multicenter clinical trial has found that a minimally invasive procedure called transcatheter mitral valve repair significantly reduced hospitalizations and mortality for heart failure patients with moderate-to-severe or severe functional mitral regurgitation.
This first randomized clinical study of a polymer-coated zotarolimus-eluting stent (Resolute Onyx) that utilizes a novel thin-strutted metallic platform allowing for better x-ray visibility was shown to be non-inferior to an ultrathin-strutted bioresorbable polymer-coated sirolimus-eluting stent (Orsiro) that uses a cobalt-chromium strut platform.
The first large, randomized trial comparing a novel polymer-free amphilimus-eluting stent to the latest-generation permanent polymer drug-eluting stent found that the polymer-free stent was clinically safe and effective.
Study shows there is a genetic predisposition to early-onset AFib in blacks and Latinos that is greater than what is observed in whites.
A new study published in the Journal of the American Heart Association shows disparities between the care given to black and white patients seeking treatment for a type of heart attack called NSTEMI (Non-ST-elevation myocardial infarction).
Attention has focused on how NSAIDs may cause dysfunction of the immune system. Researchers now have found that sub-acute pretreatment with the NSAID carprofen before experimental heart attack in mice impaired resolution of acute inflammation following cardiac injury.
MyoKardia, a clinical-stage biopharmaceutical company pioneering precision medicine for the treatment of cardiovascular diseases, today announced the launch of the MyoSeeds™ Research Grants Program, a new initiative to support original, independent research in the biology and underlying mechanisms of cardiomyopathies and precision heart disease treatment with the goal of improving the lives of patients.
Separated entry and exit doors for calcium keep energy production smooth in the powerhouses of heart cells.
Case Western Reserve University School of Medicine has received a three-year, $1,118,556 grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health to investigate a new imaging approach for diagnosing peripheral arterial disease, a common and potentially serious circulatory problem. More than 200 million people worldwide suffer from the condition.
A new study finds that patients who underwent TAVR had a significantly shorter length of stay and were significantly less likely to be transferred to a skilling nursing facility compared to patients who underwent SAVR.
In a proof of concept study, scientists at Johns Hopkins report they have successfully performed 3D personalized virtual simulations of the heart to accurately identify where cardiac specialists should electrically destroy cardiac tissue to stop potentially fatal irregular and rapid heartbeats in patients with scarring in the heart. The retrospective analysis of 21 patients and prospective study of five patients with ventricular tachycardia, the researchers say, demonstrate that 3D simulation-guided procedures are worthy of expanded clinical trials.
The University of Chicago Medicine and Almoosa Specialist Hospital, a private hospital in the Al-Ahsa region of Saudi Arabia offering comprehensive medical care, have signed a collaboration agreement.
Epidemiological studies have established a strong correlation between inhaling ultrafine particles from incomplete combustion and respiratory and cardiovascular diseases. Still, relatively little is known about the mechanisms behind how air particulates affect human health. New work with carbon nanodots seeks to provide the first model of how ultrafine carbon-based particles interact with the lung tissues. Researchers created a 3D lung cell model system to investigate how carbon-based combustion byproducts behave as they interact with human epithelial tissue. They discuss their work in Biointerphases.
In mouse experiments, scientists have shown a way to hit an immunological “reset button” that ends inappropriately sustained inflammation. This reset reverses the pathologic enlargement and pumping failure of the heart, and it suggests a therapeutic approach to treating human heart failure.
The Hypertrophic Cardiomyopathy Program at the University of Maryland Heart & Vascular Center (UMHVC) has been recognized as a Center of Excellence by the Hypertrophic Cardiomyopathy Association (HCMA) – one of about 30 Centers of Excellence nationwide and the only HCMA-recognized center in Maryland.
In addition to reducing overall heart failure by 25 percent, increased physical activity benefited two heart failure subtypes defined by cardiac function: reduced ejection fraction, which typically has a worse prognosis, and preserved ejection fraction, which is more common in older adults, especially women and racial-ethnic minorities.
A study led by researchers at the Peter Munk Cardiac Centre (PMCC) at UHN suggests that the model used by the Canadian Institute for Health Information (CIHI) significantly underestimates mortality in specialized heart surgery centres. The findings show that CIHI's model does not capture all of the medical problems that patients at high risk for surgery have.
The Cardiovascular Research Foundation (CRF) has announced the press conference schedule for late-breaking trials and late-breaking clinical science that will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2018 scientific symposium. TCT, the world’s premier educational meeting specializing in interventional cardiovascular medicine, will take place September 21-25 in San Diego, California.
Having atrial fibrillation (AFib) can increase your risk for stroke and heart failure. It’s vital to know your risk and get help before it strikes.
Craig A. Thompson, MD, MMSc , whose seminal, pioneering achievements are now a standard of care for re-vascularization of totally blocked coronary arteries, has been named director of cardiac catheterization laboratories at NYU Langone Health System .
Professor of Psychology Melinda Green is greatly expanding her research on eating disorders with the notification that she’s been awarded a grant for nearly $400,000 from the National Institute of Mental Health.
The latest research, features and announcements in healthcare in the Healthcare News Source
The National Institute on Aging, part of the National Institutes of Health (NIH), has awarded Wake Forest School of Medicine researchers a five-year grant worth more than $18 million to study the connections between heart health and brain health among participants in the Multi-Ethnic Study of Atherosclerosis (MESA).
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right